Trial intelligence / Profile preview

Low-dose esketamine for postoperative fatigue after gynecological laparoscopic surgery

ChiCTR2500112382Phase 4Not yet recruiting

Sponsor
The Third Affiliated Hospital of Southern Medical University
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine (2 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Postoperative fatigue incidence. Planned start Nov 2025; status: not yet recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2500112382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500112382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call